Home » Topics » Regulatory » Patents

Patents
RSS

Glaxo Wellcome describes antitumor antibody conjugates

July 5, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Pharmacia & Upjohn reports taxane derivatives

July 5, 1996

Pfizer's CJ-12798 claimed as immunosuppressant, antifungal and antitumor agent

July 5, 1996

Immunostimulants claimed by Italfarmaco

July 5, 1996

Eisai claims prostaglandin/leukotriene production inhibitors for pain and inflammation

July 5, 1996

Searle claims NOS inhibitors

July 5, 1996

BMS describes antifungal effects of ascosteroside

July 5, 1996

Lilly's 5-HT1F agonists for migraine

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
Initial data hint that US MFN pricing is hitting access in Europe
BioWorld
There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...